These directional associations, coupled with previous work implicating SREBF1 in type 2 diabetes risk via adiponectin [54, 55] and the plausible relevance of ADIPOQ as the gene encoding adiponectin, reinforce these CpGs as promising epigenetic markers. Here, ADIPOQ is linked to type 2 diabetes mellitus.